prometheus biosciences：Merck Completes Acquisition of Prometheus Biosciences

Merck Completes Acquisition of Prometheus Biosciences

2023年6月16日—Prometheusisnowawholly-ownedsubsidiaryofMerckandthecommonstockofPrometheuswillnolongerbelistedortradedontheNasdaqGlobal ...。其他文章還包含有：「MerckStrengthensImmunologyPipelinewithAcquisitionof...」、「MercktobuyPrometheusBiosciencesforabout$11billion」、「OurStory」、「PrometheusBiosciences」、「PrometheusBiosciences」、「PrometheusBiosciences」、「PrometheusPipeline」、「瞄...

查看更多離開網站

Provide From Google

Merck Strengthens Immunology Pipeline with Acquisition of ...

https://www.merck.com

Prometheus Biosciences, Inc. is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, ...

Provide From Google

Merck to buy Prometheus Biosciences for about $11 billion

https://www.reuters.com

Merck & Co said on Sunday it will buy Prometheus Biosciences Inc for about $10.8 billion, picking up a promising experimental treatment for ...

Provide From Google

Our Story

https://www.prometheusbioscien

At Prometheus Biosciences, we aim to transform the paradigm of patient care with a proprietary precision-based approach to IBD and immune-mediated diseases.

Provide From Google

Prometheus Biosciences

https://www.crunchbase.com

Prometheus Biosciences develops and commercializes pharmaceutical and diagnostic products to help physicians individualize patient care.

Provide From Google

Prometheus Biosciences

https://www.prometheusbioscien

Prometheus Biosciences is a biotechnology company specializing in developing precision therapies for immune-mediated diseases using a one-of-a-kind ...

Provide From Google